To analyze the role of CNPY2 in human liver cancer, we next explored the relationship between CNPY2 expression with clinicopathological variables in HCV+ HCCs by immunohistochemistry (Figure 4, Table 3 and Table S2). The gene discussed is CNPY2; the disease is liver cancer.